Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,620 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05920174Recruiting
Implant test to help movement in people with severe paralysis
This trial studies whether an implanted device that can record and stimulate brain signals is safe and may improve movement in people with motor disability from certain nerve or brain conditions. It’s for adults with stable, long-lasting paralysis and good brain function who can follow the study plan.
Beijing, Beijing MunicipalityAges 18–80 - NCT05920798RecruitingPhase 1/Phase 2
Vaccine treatment plus pembrolizumab for recurrent ovarian cancer
This Phase 1/2 trial tests a new cancer vaccine therapy combined with pembrolizumab (an immunotherapy) to treat advanced, recurrent ovarian, fallopian tube, or primary peritoneal cancer. It may help your immune system recognize and attack the cancer, especially if your tumor has a specific target called FRα.
Scottsdale, ArizonaAges 18 years+ - NCT05922176Recruiting
Microneedle patch testing to predict allergy treatment response
This study uses a small microneedle patch to collect skin-related samples to help predict how well allergy immunotherapy may work. It includes people with house dust mite allergy and also a healthy control group, so researchers can compare biomarker results.
SeoulAges 19–60 - NCT05923905RecruitingPhase 4
Study of FB1006 for people with early ALS
This trial tests whether FB1006 is safe and works better than usual care for treating amyotrophic lateral sclerosis (ALS). It focuses on people with relatively early ALS and good breathing function.
Beijing, Beijing MunicipalityAges 18–80 - NCT05925621Recruiting
Registry for early Alzheimer-related memory problems
This study registry collects health and brain-testing information for people with mild cognitive impairment or early Alzheimer’s dementia. It may help researchers better understand early Alzheimer disease and plan future treatments.
Boston, MassachusettsAges 50–95 - NCT05925790Recruiting
Testing immune markers in recurring pericarditis
This study looks at immune blood markers to understand different types of recurring inflammation around the heart (pericarditis). The goal is to see whether certain marker patterns (like IL-1RA antibodies and suPAR) are linked to inflammation and what might be driving it.
HomburgAges 18–90 - NCT05926492RecruitingPhase 2
Surufatinib plus chemotherapy before surgery for osteosarcoma
This Phase 2 trial studies whether surufatinib combined with chemotherapy given before surgery can shrink osteosarcoma and improve outcomes. It may help by attacking the tumor from more than one angle before the main treatment step.
Hangzhou, ZhejiangAges 2–70 - NCT05926622Recruiting
Testing a Medacta shoulder replacement system for pain relief
This trial studies how well a Medacta shoulder replacement works by looking at clinical results and X-ray/scan findings after surgery. It may help people with certain shoulder conditions who need shoulder replacement or revision surgery.
AnnecyAges 18 years+ - NCT05927519Recruiting
Compare a laryngoscope tool in obese vs nonobese men
This study compares how well a specific breathing tube placement tool (Airtraq) works in men who are obese versus men who are not, during planned surgeries. It may help improve the safety and ease of putting in a breathing tube.
IamitAges 18–80 - NCT05928598Recruiting
Learning goals for epilepsy clinic visits
This study asks adults with hard-to-control epilepsy to share what goals they want from their epilepsy clinic visits. It may help the clinic improve visit planning to better support patients day to day.
Ann Arbor, MichiganAges 18 years+ - NCT05928767Recruiting
Using frailty scores to predict death in ICU sepsis
This trial checks whether a “frailty” rating (how physically/mentally vulnerable someone is) can predict the risk of death in ICU patients with sepsis shock. It may help doctors identify higher-risk patients earlier and tailor care.
BéthuneAges 18–65 - NCT05932589Recruiting
Study of brain signals as signs of Rett syndrome
This study measures brain and nerve activity (brain signals) to find patterns that match Rett syndrome. It may help researchers better track Rett changes over time and develop more precise ways to measure response in future treatments.
Los Angeles, CaliforniaAges 1–18 - NCT05933161Recruiting
Testing diabetes blood-sugar tracking for people with an LVAD
This study looks at how well people with an LVAD can manage their blood sugar when they use a continuous glucose monitor app on a smartphone. It may help your diabetes care team adjust treatment using more complete sugar data.
Rochester, MinnesotaAges 18 years+ - NCT05935150Recruiting
Skipping lymph node surgery in early breast cancer
This trial studies whether you can safely avoid a lymph node biopsy in the armpit for early breast cancer when scans and exams look negative. It may reduce surgery-related side effects while still keeping cancer care on track.
Nanjing, JiangsuAges 18–70 - NCT05935605Recruiting
Study pulmonary hypertension in heart failure and valve disease
This study looks at pulmonary hypertension—high blood pressure in the lung arteries—in people with certain heart conditions (heart failure with preserved or reduced pumping function, or significant valve disease). It may help doctors better understand how lung blood pressure changes in these heart problems and guide care.
Rochester, MinnesotaAges 18 years+ - NCT05937620Recruiting
Mapping ovarian cancer sentinel nodes with two injected dyes
This study checks whether doctors can find the first lymph node(s) where ovarian cancer may spread using two dyes (a radioactive tracer and a green dye). It may help surgeons do more precise staging and treatment planning.
Barcelona, CataloniaAges 18 years+ - NCT05940311Recruiting
Blood test for melanoma with BRAF V600E mutation
This trial studies a very sensitive blood test to detect melanoma-related genetic changes in people with BRAF V600E. It may help track the disease more closely and guide care in advanced or high-risk situations.
RomeAges 18 years+ - NCT05942729Recruiting
Checking heart disease diagnosis using echo images and health data
This study looks at how well heart ultrasound (echocardiography) images and clinical information can be used to diagnose cardiac conditions. If you have a clear ultrasound study already or can get one with good image quality, your information may help improve diagnostic accuracy.
Pierre-BéniteAges 18 years+ - NCT05944016RecruitingPhase 3
Dapagliflozin for early Alport kidney disease in teens and young adults
This trial tests dapagliflozin, a daily medicine, to slow kidney problems in people with early-stage chronic kidney disease caused by Alport syndrome. It may help protect kidney function and reduce worsening over time.
Heidelberg, Baden-WürttenbergAges 10–39 - NCT05946850Recruiting
Caudal pain block study for adults with chronic pain
This trial looks at giving a specific pain procedure called caudal analgesia to adults with long-term (chronic) pain. It may help reduce pain after the procedure, and it will compare results for people who can safely receive it.
Surrey, British ColumbiaAges 20–99 - NCT05947695Recruiting
Nurse-led comfort and survivorship care for advanced cancer
This study looks at whether a specialized nurse-led care plan soon after diagnosis/treatment helps people living with advanced (metastatic) cancer. It focuses on patients expected to do better than average based on certain prognosis factors.
West Islip, New YorkAges 21 years+ - NCT05950022Recruiting
Endoscopic release of the iliopsoas tendon during hip replacement pain
This study looks at whether an endoscopic “cut/release” of the iliopsoas tendon can improve hip symptoms caused by rubbing against a hip prosthesis. It is meant for adults whose first non-surgical treatments did not help.
LyonAges 18 years+ - NCT05952141Recruiting
Help close delays from cervical cancer diagnosis to treatment
This study aims to find practical ways to shorten the time between a cervical cancer diagnosis and starting treatment, using Botswana’s local testing system. If you are eligible, the study may help improve how quickly and smoothly patients get care after diagnosis.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05958017Recruiting
ReSET program to help stimulant use in HIV clinics
This study tests a care-support program called ReSET to improve adherence to treatment and reduce stimulant use for people living with HIV who are not currently in drug treatment. You may be offered support through HIV clinic care to help you stay on track, especially if you have access to a smartphone and stable housing.
Miami, FloridaAges 18–90
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,620 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.